InsiderChairman

Joel S Marcus Insider Trading Activity

Every SEC Form 4 transaction reported by Joel S Marcus, sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Is Joel S Marcus buying or selling?

Joel S Marcus reported 8 open-market buys ($5.0M) and 53 sells ($93.6M) across 61 Form 4 filings at 6 companies — a net selling position of $88.6M.

Source: SEC EDGAR Form 4

Key Statistics (as of May 7, 2026)

Total Form 4 filings
61
SEC EDGAR
Companies
6
Buys (8)
$5.0M
Sells (53)
$93.6M

Insider sentiment

Net selling

Net insider flow of $88.6M in net selling, filed between May 7, 2018 – May 7, 2026.

Companies Joel S Marcus files for

#CompanyForm 4 filings
1AREALEXANDRIA REAL ESTATE EQUITIES, INC.37
2ITCIIntra-Cellular Therapies, Inc.11
3ATRAAtara Biotherapeutics, Inc.4
4KRROFrequency Therapeutics, Inc.4
5APLTApplied Therapeutics Inc.3
6MGTXMeiraGTx Holdings plc2

Recent Joel S Marcus transactions

DateTickerRoleTypeSharesValue
May 7, 2026AREExecutive ChairmanPurchase7.5K$347.6K
May 6, 2026AREExecutive ChairmanPurchase7.5K$320.4K
May 5, 2026AREExecutive ChairmanPurchase10.0K$410.2K
Feb 13, 2026AREExecutive ChairmanPurchase25.0K$1.3M
Feb 28, 2024AREExecutive ChairmanSale7.5K$891.9K
Feb 28, 2024ITCIDirectorSale26.3K$1.8M
May 10, 2023AREExecutive ChairmanSale7.5K$916.5K
Feb 9, 2023AREExecutive ChairmanSale9.0K$1.5M
Dec 21, 2022ITCIDirectorSale5.0K$254.1K
Dec 14, 2022AREExecutive ChairmanSale6.5K$975.0K
Dec 7, 2022AREExecutive ChairmanSale2.5K$380.0K
Nov 8, 2022ITCIDirectorSale10.0K$523.0K
Aug 12, 2022ITCIDirectorSale10.0K$592.2K
May 13, 2022ITCIDirectorSale10.0K$550.0K
Mar 10, 2022ITCIDirectorSale20.0K$1.1M
Aug 11, 2021AREExecutive ChairmanSale7.5K$1.6M
Aug 4, 2021AREExecutive ChairmanSale5.0K$1.0M
Jul 30, 2021AREExecutive ChairmanSale20.0K$4.0M
Jun 15, 2021ITCIDirectorSale18.3K$773.1K
May 5, 2021AREExecutive ChairmanSale20.0K$3.6M
Mar 4, 2021ITCIDirectorSale15.3K$532.7K
Dec 22, 2020KRRODirectorSale49.7K$1.7M
Aug 19, 2020AREExecutive ChairmanSale7.5K$1.3M
Aug 12, 2020MGTXDirectorSale15.5K$216.6K
Aug 4, 2020AREExecutive ChairmanSale45.0K$7.9M

Showing the 25 most recent filings of 61. Screen every filing.

Joel S Marcus insider trading FAQ

Is Joel S Marcus buying or selling?

Across 61 SEC Form 4 filings, Joel S Marcus reported 8 open-market purchases totaling $5.0M and 53 sales totaling $93.6M — a net selling position of $88.6M.

Which companies does Joel S Marcus file Form 4s for?

Joel S Marcus has reported insider transactions at 6 companies, most often ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE), Intra-Cellular Therapies, Inc. (ITCI), Atara Biotherapeutics, Inc. (ATRA), Frequency Therapeutics, Inc. (KRRO), Applied Therapeutics Inc. (APLT).

How far back does Joel S Marcus's filing history go?

Trabud holds Joel S Marcus's SEC Form 4 filings from May 7, 2018 – May 7, 2026, sourced directly from SEC EDGAR.

Where does Trabud get Joel S Marcus's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track Joel S Marcus and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener